IL-5 Inhibitor Treatment in Drug Reaction With Eosinophilia and Systemic Symptoms
This case series evaluates the safety and efficacy of IL-5 inhibition for the treatment of drug reaction with eosinophilia and systemic symptoms.
Authors
- Baraa Hijaz (ORCID: https://orcid.org/0000-0002-1192-1812)
- Sotonye Imadojemu (ORCID: https://orcid.org/0000-0001-9049-9690)
- Vinod E. Nambudiri (ORCID: https://orcid.org/0000-0002-4170-7681)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1001/jamadermatol.2025.0441
- Citations
- 1
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.39